# OnCo record edoxaban (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/edoxaban/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "edoxaban" ;
  schema:name "Edoxaban"@en ;
  schema:description "Edoxaban is a blood-thinning tablet. For a clot in someone with cancer it is started after at least five days of heparin injections."@en ;
  schema:url <https://onco.cc/drugs/edoxaban/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Edoxaban> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d3400-56ad-11e3-949a-0800200c9a66>, <https://doi.org/10.1016/S1470-2045(22)00160-7> ;
  onco:status "approved" ;
  onco:tag "supportive", "generic", "supportive-care-gaps-2026-11" ;
  onco:modality "Direct oral anticoagulant (factor Xa inhibitor, tablet)" ;
  schema:alternateName "Savaysa / Lixiana" ;
  onco:approval "US 2015: Stroke prevention in non-valvular atrial fibrillation; treatment of DVT and PE after 5 to 10 days of parenteral anticoagulation" ;
  onco:related <https://onco.cc/drugs/apixaban/>, <https://onco.cc/drugs/rivaroxaban/> ;
  onco:technologies <https://onco.cc/technologies/cancer-associated-thrombosis/> ;
  onco:terms <https://onco.cc/terms/vte/> .